p. 235−247
1735-3688
Vol.43/No.3
p. 248−260
1735-3688
Vol.43/No.3
p. 261−268
1735-3688
Vol.43/No.3
p. 269−275
1735-3688
Vol.43/No.3
p. 276−285
1735-3688
Vol.43/No.3
p. 286−295
1735-3688
Vol.43/No.3
p. 296−304
1735-3688
Vol.43/No.3
p. 305−312
1735-3688
Vol.43/No.3
351 cases/year (22.9% of the treated patients). The cancer site distribution of the eligible Fars residents was central nervous system primary tumors (n=31), brain metastases (n=64), eye (n=7), head and neck (n=28); thyroid (n=4), lung (n=17), breast (n=56), esophagus (n=5); pancreas (n=5), gastric (n=32), liver and bile duct (n=0), rectum and anus (n=26); prostate (n=27), bladder (n=8), cervix (n=6), soft tissue (n=17); kidney (n=1), Hodgkin lymphoma (n=9), non-Hodgkin lymphoma (n=4), and bone metastases (n=4). A total number of 5,756 cases/year was estimated for the entire country. Considering the experiences of other countries, these results suggest that establishing at least two HT centers (covering the northern and southern parts of Iran) is justified based on the total number of patients. Further accurate estimations and cost evaluations are recommended.]]>
p. 313−317
1735-3688
Vol.43/No.3
A, IVS7-5T>C, and p.P281L with the frequency of 27.8%, 11%, and 11%, respectively. The results showed that there is not only a consanguineous relation, but also a difference in PAH characters of mutations between Kermanshah and the other two parts of western Iran (Hamadan and Lorestan). Also, it seems that the spectrum of mutations in western Iran is relatively distinct from other parts of the country, suggesting that this region might be a special PAH gene distribution region. Moreover, our findings can be useful in the identification of genotype to phenotype relationship in patients, and provide future abilities for confirmatory diagnostic testing, prognosis, and predict the severity of PKU patients.]]>
p. 318−323
1735-3688
Vol.43/No.3
p. 324−327
1735-3688
Vol.43/No.3
p. 328−331
1735-3688
Vol.43/No.3
p. 332−335
1735-3688
Vol.43/No.3
p. 336−339
1735-3688
Vol.43/No.3
p. 340−341
1735-3688
Vol.43/No.3